Join Mike Auerbach, editor-in-chief at American Pharmaceutical Review and Debra Barberini, PhD, MaxCyte business development manager, as they discuss MaxCyte's role in the cell and gene therapy market, how they've evolved to meet the changing needs and demands of this industry, and innovations for the future.
QC Corner: Environmental Monitoring: expert discussion on the benefits of a single incubation temperature